GO:0033699 DNA 5'-adenosine monophosphate hydrolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033699 describes the enzymatic removal of a covalently linked adenosine monophosphate (AMP) from the 5' end of a DNA strand, leaving a 5' phosphate terminus.
• This activity is central to DNA deadenylation, a process that reverses the covalent DNA-adenylate intermediate formed during DNA ligation and repair.
• The reaction produces AMP and a 5'-phosphorylated DNA end, which is essential for downstream DNA repair, replication, and recombination.
• Dysregulation of DNA deadenylation can lead to persistent DNA breaks, genomic instability, and activation of innate immune sensing pathways such as cGAS-STING.
• Key proteins with this activity include enzymes involved in DNA repair and R-loop processing, such as those that resolve RNA-DNA hybrids and prevent autoimmune activation.
• Studying GO:0033699 requires a combination of biochemical assays, CRISPR knockout models, and advanced sequencing to track DNA end modifications.
Description
DNA 5'-adenosine monophosphate hydrolase activity (GO:0033699) is a molecular function that catalyzes the hydrolysis of a covalent adenylate linkage at the 5' terminus of a DNA strand, releasing AMP and generating a 5' phosphate end. This activity is critical for reversing DNA adenylation, a modification that occurs as an intermediate in DNA ligation and repair processes. The reaction is essential for maintaining genomic integrity, as failure to remove AMP can block subsequent DNA transactions and trigger cellular stress responses. Researchers study this activity to understand how cells resolve DNA damage, process R-loops, and avoid inappropriate immune activation by self-DNA. The term is particularly relevant in cancer biology and autoimmunity, where defects in DNA deadenylation can lead to genomic instability and chronic inflammation.
DNA 5'-adenosine monophosphate hydrolase activity At A Glance
| GO ID | GO:0033699 |
|---|---|
| GO term | DNA 5'-adenosine monophosphate hydrolase activity |
| Ontology | molecular_function |
| Synonym | AMP-removal activity, DNA 5'-adenylate hydrolase activity, DNA adenylate hydrolysis activity, DNA de-adenylation, DNA deadenylation |
| Major function | Removal of AMP from 5' DNA ends to generate 5' phosphate termini |
| Substrate | 5'-adenylated DNA (deoxyribonucleoside or ribonucleoside-2'-deoxyribonucleotide) |
| Products | 5'-phosphorylated DNA, AMP, and 2 H+ |
| Reaction type | Hydrolysis (nucleophilic release of adenylate) |
| Biological context | DNA repair, replication, recombination, and R-loop processing |
What Is GO:0033699?
GO:0033699 is defined as the catalysis of two related reactions: the hydrolysis of a 5'-end adenosine-5'-diphospho-5'-2'-deoxyribonucleoside-DNA to yield a 5'-end 5'-phospho-2'-deoxyribonucleoside-DNA, AMP, and two protons; and the hydrolysis of a 5'-end adenosine-5'-diphospho-5'-ribonucleoside-2'-deoxyribonucleotide-DNA to yield a 5'-end 5'-phospho-ribonucleoside-2'-deoxyribonucleotide-DNA, AMP, and two protons. In essence, it is the nucleophilic release of a covalently linked adenylate residue from a DNA strand, leaving a 5' phosphate terminus. This activity is also known as AMP-removal activity, DNA 5'-adenylate hydrolase activity, DNA adenylate hydrolysis activity, DNA de-adenylation, or DNA deadenylation.
Why Is DNA 5'-adenosine monophosphate hydrolase activity Important in Cell Biology?
DNA 5'-adenosine monophosphate hydrolase activity is essential for maintaining genomic stability by reversing DNA adenylation, a modification that can otherwise block DNA repair and replication. This activity also prevents the accumulation of aberrant DNA structures that can activate innate immune responses, such as the cGAS-STING pathway, which is implicated in autoimmunity and cancer. Understanding this activity provides insights into how cells manage DNA damage and how defects contribute to diseases like cancer and inflammatory disorders.
• Enables completion of DNA repair by removing adenylate groups from 5' ends, allowing ligation or further processing.
• Prevents genomic instability by ensuring proper resolution of DNA breaks and recombination intermediates.
• Limits inappropriate activation of the cGAS-STING innate immune pathway by self-DNA.
• Plays a role in R-loop metabolism, as R-loop-derived RNA-DNA hybrids can activate immune responses if not properly processed.
• Dysregulation is linked to cancer progression through chronic inflammation and genome instability.
• Potential therapeutic target for autoimmune diseases where DNA sensing is overactive.
• Important for understanding the mechanisms of DNA ligation and repair in basic research.
• Relevant to the development of CRISPR-based gene editing tools, which rely on DNA repair pathways.
• May influence the efficacy of cancer therapies that induce DNA damage.
• Contributes to the maintenance of cellular homeostasis by preventing toxic DNA intermediate accumulation.
What Happens During DNA 5'-adenosine monophosphate hydrolase activity?
Substrate Recognition and Binding
In simple terms: The enzyme finds and grabs onto a DNA end that has an AMP molecule attached.
The enzyme recognizes a 5'-adenylated DNA substrate, which can be a deoxyribonucleoside or a ribonucleoside-2'-deoxyribonucleotide linked to AMP. This adenylated intermediate typically arises during DNA ligation or repair processes, where AMP is covalently attached to the 5' phosphate of a DNA strand. The enzyme binds to this modified DNA end with high specificity, positioning the adenylate group for hydrolysis.
Catalytic Hydrolysis of the Adenylate Linkage
In simple terms: The enzyme uses water to cut the bond between AMP and the DNA, releasing AMP.
Once bound, the enzyme catalyzes a nucleophilic attack by water on the phosphodiester bond between the AMP and the DNA 5' phosphate, resulting in the release of AMP and the formation of a 5' phosphate terminus on the DNA. This reaction also produces two protons, as indicated in the GO definition. The hydrolysis is essential for regenerating a ligatable or processable DNA end.
Product Release and DNA End Processing
In simple terms: After AMP is removed, the DNA end is free to participate in other processes like repair or replication.
Following hydrolysis, the 5'-phosphorylated DNA is released from the enzyme, allowing it to serve as a substrate for subsequent DNA repair, replication, or recombination events. The removal of AMP is critical because the adenylate group can otherwise block ligation or further enzymatic processing. This step ensures that DNA ends are in the correct chemical state for downstream pathways.
Role in R-Loop and Immune Surveillance
In simple terms: This activity helps clean up DNA-RNA hybrids that could otherwise trigger an immune alarm.
DNA deadenylation is implicated in the processing of R-loops, which are RNA-DNA hybrids that can form during transcription. If not properly resolved, R-loop-derived cytoplasmic RNA-DNA hybrids can activate an immune response through pathways such as cGAS-STING. By removing AMP from DNA ends, this activity may contribute to the resolution of such structures and prevent autoimmune activation.
Integration with DNA Repair Pathways
In simple terms: The enzyme works together with other repair proteins to fix broken DNA.
The 5' phosphate generated by DNA deadenylation is a prerequisite for many DNA repair pathways, including non-homologous end joining and homologous recombination. Enzymes with this activity may cooperate with repair factors such as MRE11 or MLH1 to ensure proper processing of DNA breaks. Defects in this activity can lead to persistent DNA damage and genomic instability.
Key Genes Involved in GO:0033699 DNA 5'-adenosine monophosphate hydrolase activity
The following genes and proteins are associated with DNA 5'-adenosine monophosphate hydrolase activity or related DNA deadenylation processes, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TREX1 | ER-directed exonuclease that limits cGAS activation at micronuclei | Studied for its role in preventing autoimmune responses by degrading cytosolic DNA |
| cGAS | DNA sensor that activates STING upon binding to double-stranded DNA | Central to innate immune sensing of self-DNA; regulated by DNA modifications |
| STING | Adaptor protein in the cGAS-STING pathway that induces interferon responses | Key mediator of immune activation by aberrant DNA |
| MLH1 | Mismatch repair protein; deficiency triggers DNA hyperexcision and cGAS-STING activation | Links DNA repair defects to immune activation |
| MRE11 | Component of the MRN complex involved in DNA double-strand break repair | Liberates cGAS from nucleosome sequestration during tumorigenesis |
| G3BP1 | RNA-binding protein that promotes DNA binding and activation of cGAS | Modulates cGAS activity in response to DNA damage |
| EXO1 | Exonuclease involved in DNA resection during repair | Its hyperexcision activity in MLH1 deficiency activates cGAS-STING |
| R-loop processing factors | Enzymes that resolve RNA-DNA hybrids | Prevent immune activation by R-loop-derived hybrids |
| DNA ligases | Enzymes that seal DNA breaks via adenylated intermediates | Their reverse reaction is DNA deadenylation |
| Poly(ADP-ribose) polymerases | Sensors of DNA breaks that recruit repair factors | May influence DNA end modifications |
| ATM/ATR kinases | DNA damage response kinases | Coordinate repair and cell cycle arrest upon DNA damage |
| DNA-PK | Kinase involved in non-homologous end joining | Processes DNA ends during repair |
| XRCC4 | Ligase IV cofactor in non-homologous end joining | Works with ligase to seal breaks |
| LIG4 | DNA ligase IV that catalyzes ligation of DNA ends | Its activity generates adenylated intermediates |
| APEX1 | AP endonuclease in base excision repair | Processes DNA ends with 5' modifications |
| FEN1 | Flap endonuclease in DNA replication and repair | Removes 5' flaps, generating ligatable ends |
| PCNA | Proliferating cell nuclear antigen; processivity factor | Coordinates DNA replication and repair |
| RPA | Single-stranded DNA-binding protein | Protects DNA ends during repair |
How Is DNA 5'-adenosine monophosphate hydrolase activity Regulated?
DNA 5'-adenosine monophosphate hydrolase activity is regulated at multiple levels, including through the DNA damage response kinases ATM and ATR, which coordinate repair pathways. The activity may also be influenced by the availability of adenylated DNA substrates, which are generated during DNA ligation and repair. Additionally, innate immune signaling through cGAS-STING can be modulated by the removal of AMP from DNA ends, as persistent adenylation may lead to immune activation. Post-translational modifications of enzymes involved in this activity, such as acetylation, have been shown to regulate cGAS activity, suggesting similar regulatory mechanisms may apply.
DNA 5'-adenosine monophosphate hydrolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TREX1 | Autoimmunity (Aicardi-Goutières syndrome) | TREX1 knockout cells or mouse models |
| MLH1 | Cancer (colorectal, endometrial) | MLH1-deficient cell lines and xenografts |
| MRE11 | Cancer (breast, ovarian) | MRE11 knockout or point-mutant models |
| cGAS | Autoimmunity, cancer | cGAS knockout or overexpression cells |
| STING | Infectious disease, autoimmunity | STING knockout mice or cells |
Cancer and Genomic Instability
Defects in DNA deadenylation can lead to persistent DNA breaks and genomic instability, which are hallmarks of cancer. For example, MLH1 deficiency causes DNA hyperexcision by exonuclease 1, activating the cGAS-STING pathway and promoting tumorigenesis. Similarly, MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis, linking DNA repair defects to immune activation. These findings suggest that enzymes with DNA 5'-adenosine monophosphate hydrolase activity may act as tumor suppressors by preventing the accumulation of immunostimulatory DNA.
Autoimmunity and Chronic Inflammation
Impaired removal of AMP from DNA ends can result in the accumulation of aberrant DNA species that activate the cGAS-STING pathway, leading to chronic inflammation and autoimmune diseases such as Aicardi-Goutières syndrome. TREX1, an ER-directed exonuclease, limits cGAS activation at micronuclei, and its dysfunction is associated with autoimmunity. Acetylation of cGAS blocks its activity and inhibits self-DNA-induced autoimmunity, highlighting the importance of regulating DNA sensing.
Infectious Disease and Immune Evasion
The cGAS-STING pathway, which can be influenced by DNA deadenylation, plays a role in defense against pathogens such as influenza virus. STING-NF-κB signaling builds an influenza spillover barrier, and autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Thus, proper regulation of DNA modifications may impact host-pathogen interactions.
From DNA 5'-adenosine monophosphate hydrolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DNA deadenylation cause genomic instability? | CRISPR knockout of candidate genes (e.g., TREX1) in cell lines |
| How does a point mutation affect catalytic activity? | Point mutation knock-in of catalytic residues in candidate enzymes |
| What is the subcellular localization of the enzyme? | Tagged knock-in with fluorescent protein for imaging |
| Does overexpression of the enzyme suppress immune activation? | Overexpression cell models with cGAS-STING reporter |
| Which genes are synthetic lethal with DNA deadenylation defects? | CRISPR library screening in knockout backgrounds |
| Can small molecules modulate DNA deadenylation? | High-throughput biochemical assays with purified enzyme |
How to Study the DNA 5'-adenosine monophosphate hydrolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro deadenylation assay | Release of AMP and formation of 5' phosphate | Enzyme kinetics and inhibitor testing |
| CRISPR knockout screen | Gene essentiality and synthetic lethality | Identifying regulators of DNA deadenylation |
| STING reporter assay | Activation of innate immune signaling | Assessing immune consequences of DNA deadenylation |
| RNA-seq | Transcriptional changes | Global gene expression profiling upon enzyme modulation |
| Proteomics | Protein interactions and modifications | Identifying binding partners of deadenylases |
| Chromatin immunoprecipitation (ChIP) | Protein-DNA interactions | Studying recruitment to DNA damage sites |
| Fluorescence microscopy | Subcellular localization | Visualizing tagged enzymes in live cells |
| Mass spectrometry | Detection of AMP and modified DNA | Direct biochemical characterization |
Biochemical Assays for Deadenylation Activity
In vitro assays using synthetic adenylated DNA substrates can directly measure the release of AMP and the formation of 5' phosphate ends. These assays typically employ purified enzymes or cell lysates and detect products via gel electrophoresis, mass spectrometry, or fluorescent probes. Such methods are essential for characterizing the catalytic mechanism and identifying inhibitors.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate DNA deadenylation and its downstream effects. For example, screens in MLH1-deficient cells revealed synthetic lethal interactions with DNA repair pathways. These screens are powerful for uncovering novel regulators and therapeutic targets.
Immune Activation Readouts
Reporter cell lines expressing interferon-stimulated genes or luciferase under the control of the cGAS-STING pathway can be used to measure the impact of DNA deadenylation on innate immunity. Such readouts help link enzymatic activity to immune phenotypes.
Advanced Sequencing and Proteomics
RNA-seq and proteomics can profile global changes in gene expression and protein interactions upon modulation of DNA deadenylation. For instance, MRE11 liberates cGAS from nucleosome sequestration, which can be studied by chromatin immunoprecipitation followed by sequencing. These approaches provide systems-level insights into the pathways affected.
How CRISPR Can Be Used to Study GO:0033699 DNA 5'-adenosine monophosphate hydrolase activity
Knockout
CRISPR knockout of genes encoding DNA deadenylases can reveal their essential roles in DNA repair and immune regulation. For example, TREX1 knockout cells accumulate cytosolic DNA and activate cGAS-STING, providing a model for autoimmunity. Knockout studies are foundational for establishing causality.
Point Mutation
Introducing point mutations in catalytic residues of candidate enzymes can dissect their enzymatic activity from other functions. Such models help determine whether deadenylation activity is required for a specific phenotype. For instance, mutating the active site of a deadenylase can abolish AMP removal without affecting protein interactions.
Knock-in
Knock-in of tagged versions of deadenylases (e.g., GFP or HA) allows for localization and interaction studies. Tagged knock-in models are valuable for imaging and proteomics. They can also be used to express mutant variants under endogenous regulatory control.
Overexpression
Overexpression of DNA deadenylases can suppress immune activation by removing immunostimulatory adenylated DNA. Overexpression models are useful for testing whether increased activity can ameliorate disease phenotypes. They also help identify downstream effects of enhanced deadenylation.
How EDITGENE Supports DNA 5'-adenosine monophosphate hydrolase activity Research
Researchers studying DNA 5'-adenosine monophosphate hydrolase activity-related genes often need to determine whether a candidate gene is causally involved in DNA repair, immune regulation, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for DNA 5'-adenosine monophosphate hydrolase activity research.
Frequently Asked Questions About DNA 5'-adenosine monophosphate hydrolase activity
What is DNA 5'-adenosine monophosphate hydrolase activity?
It is an enzymatic activity (GO:0033699) that removes a covalently linked AMP from the 5' end of DNA, leaving a 5' phosphate terminus.
What genes are involved in DNA 5'-adenosine monophosphate hydrolase activity?
Genes such as TREX1, MLH1, MRE11, and cGAS are associated with this activity or its downstream effects.
What is the role of DNA deadenylation in DNA repair?
DNA deadenylation removes AMP from DNA ends, generating 5' phosphate groups necessary for ligation and repair.
How is DNA 5'-adenosine monophosphate hydrolase activity linked to cancer?
Defects in this activity can cause genomic instability and chronic inflammation, promoting tumorigenesis.
What diseases are associated with defects in DNA deadenylation?
Autoimmune diseases like Aicardi-Goutières syndrome and various cancers have been linked to impaired DNA deadenylation.
What methods are used to study DNA 5'-adenosine monophosphate hydrolase activity?
Biochemical assays, CRISPR screens, RNA-seq, and proteomics are commonly used.
How does DNA deadenylation affect the immune system?
It prevents the accumulation of immunostimulatory DNA that activates the cGAS-STING pathway.
Can CRISPR be used to study DNA 5'-adenosine monophosphate hydrolase activity?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools for dissecting this activity.
What is the substrate of DNA 5'-adenosine monophosphate hydrolase?
The substrate is a 5'-adenylated DNA molecule, such as a 5'-end adenosine-5'-diphospho-5'-2'-deoxyribonucleoside-DNA.
What are the products of the DNA deadenylation reaction?
The products are a 5'-phosphorylated DNA, AMP, and two protons.
Conclusion
DNA 5'-adenosine monophosphate hydrolase activity (GO:0033699) is a critical enzymatic function that maintains genomic stability and regulates innate immune responses by removing AMP from DNA ends. Its dysregulation is implicated in cancer and autoimmune diseases, making it a promising target for therapeutic intervention. Continued research using CRISPR models and advanced biochemical assays will further elucidate its mechanisms and disease relevance.
References
- 1. Crossley MP et al.. 2023. R-loop-derived cytoplasmic RNA-DNA hybrids activate an immune response.. Nature 613(7942):187-194 PMID: 36544021
- 2. Ye R et al.. 2026. STING-NF-κB signaling builds an influenza spillover barrier.. Science 391(6788):eads4405 PMID: 41747053
- 3. Gui X et al.. 2019. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway.. Nature 567(7747):262-266 PMID: 30842662
- 4. Liu ZS et al.. 2019. G3BP1 promotes DNA binding and activation of cGAS.. Nat Immunol 20(1):18-28 PMID: 30510222
- 5. Mohr L et al.. 2021. ER-directed TREX1 limits cGAS activation at micronuclei.. Mol Cell 81(4):724-738.e9 PMID: 33476576
- 6. Dai J et al.. 2019. Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity.. Cell 176(6):1447-1460.e14 PMID: 30799039
- 7. Guan J et al.. 2021. MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway.. Cancer Cell 39(1):109-121.e5 PMID: 33338427
- 8. Cho MG et al.. 2024. MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis.. Nature 625(7995):585-592 PMID: 38200309
